PixArt Imaging Inc. (TPEX:3227)

Verve Therapeutics Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	5,965	4,898	4,040	3,863	4,690	4,292
Short-Term Investments	1,045	1,067	837.39	651.2	1,040	754.4
Trading Asset Securities	16.2	16.08	15.87	15.69	15.61	15.58
Cash & Short-Term Investments	7,027	5,981	4,893	4,529	5,745	5,062
Cash Growth	31.19%	22.23%	8.02%	-21.16%	13.50%	1.21%
Accounts Receivable	990.95	1,092	965.78	618.94	978.39	1,456
Other Receivables	96.64	43.01	26.49	18.11	36.98	35.99
Receivables	1,088	1,135	992.27	637.04	1,015	1,492
Inventory	1,002	950.77	680.46	988.02	1,046	769.46
Prepaid Expenses	88.37	100.27	114	54.43	56.52	64.78
Other Current Assets	59.19	24.74	38.99	30.78	-	-
Total Current Assets	9,264	8,192	6,719	6,240	7,864	7,388
Property, Plant & Equipment	1,021	1,028	930.93	977.32	881.66	866.19
Long-Term Investments	3,771	4,312	2,885	2,413	2,726	1,825
Other Intangible Assets	191.68	238.65	139.38	158.23	330.95	304.84
Long-Term Deferred Tax Assets	189.71	151.12	140.87	143.78	162.36	141.1
Other Long-Term Assets	359.1	319.25	1,361	1,351	1,554	1,356
Total Assets	14,796	14,240	12,176	11,284	13,519	11,881
Accounts Payable	494.65	443.83	445.59	236.4	695.92	559.94
Short-Term Debt	-	-	-	-	422.84	415.3
Current Portion of Long-Term Debt	-	12.59	-	-	-	-
Current Portion of Leases	27.67	22.46	21.88	22.8	24.23	21.25
Current Income Taxes Payable	212.34	342.92	200.19	172.09	230.01	267.64
Current Unearned Revenue	50.27	68.67	25.33	14.45	14.04	16.95
Other Current Liabilities	2,810	1,334	1,149	1,216	1,419	1,100
Total Current Liabilities	3,595	2,224	1,842	1,661	2,807	2,381
Long-Term Debt	24	30.3	-	-	-	-
Long-Term Leases	155.99	154.44	154.33	154.17	155.7	166.74
Long-Term Deferred Tax Liabilities	246.75	268.71	268.43	318.51	338.27	367.7
Other Long-Term Liabilities	3.72	0.5	0.5	4.22	4.31	6.52
Total Liabilities	4,025	2,682	2,273	2,151	3,323	2,943
Common Stock	1,492	1,493	1,461	1,462	1,428	1,416
Additional Paid-In Capital	3,333	3,331	2,870	2,867	2,473	2,400
Retained Earnings	5,475	5,999	4,746	4,759	5,047	4,643
Comprehensive Income & Other	419.8	669.79	825.71	44.79	1,226	458
Total Common Equity	10,721	11,492	9,903	9,133	10,174	8,916
Minority Interest	49.45	66.34	-	-	21.94	21.11
Shareholders' Equity	10,770	11,559	9,903	9,133	10,196	8,937
Total Liabilities & Equity	14,796	14,240	12,176	11,284	13,519	11,881
Total Debt	207.66	219.79	176.21	176.97	602.76	603.29
Net Cash (Debt)	6,819	5,761	4,717	4,353	5,143	4,459
Net Cash Growth	31.74%	22.14%	8.37%	-15.36%	15.33%	-7.06%
Net Cash Per Share	45.38	38.64	32.18	29.95	35.59	31.37
Filing Date Shares Outstanding	145.95	149.27	146.09	146.18	142.8	141.56
Total Common Shares Outstanding	145.95	149.27	146.09	146.18	142.8	141.56
Working Capital	5,669	5,967	4,877	4,578	5,057	5,007
Book Value Per Share	73.46	76.99	67.79	62.48	71.25	62.99
Tangible Book Value	10,529	11,254	9,764	8,975	9,843	8,612
Tangible Book Value Per Share	72.14	75.39	66.83	61.39	68.93	60.84
Land	-	153.39	153.39	153.39	62.61	62.61
Buildings	-	538.26	538.26	538.26	458.66	458.66
Machinery	-	832.6	666.75	641.92	640.52	553.53
Construction In Progress	-	11.25	-	-	-	-

Updated Mar 11, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.